Coherus Biosciences | CHRS - الربح الإجمالي على المبيعات

سعر السهم
1.75
التغيير اليومي
-0.01 -0.57%
شهريا
6.06%
سنويا
80.65%
Q2 التوقعات
1.71




الربح الإجمالي على المبيعات تغيير تاريخ
AbbVie USD 12.54B 474M 2026-03
Acadia Pharmaceuticals USD 243.27M 14.49M 2026-03
Akebia Therapeutics USD 47.28M 1.7M 2025-12
ALKERMES USD 331.33M 7M 2026-03
Alnylam Pharmaceuticals USD 825M 4.3M 2026-03
Amarin USD 23.17M 961K 2025-12
Amgen USD 6.89B 415M 2025-12
Baxter International USD 891M 314M 2026-03
Biogen USD 1.82B 169.5M 2026-03
BioMarin Pharmaceutical USD 571.21M 141.8M 2026-03
Bristol-Myers Squibb USD 8.41B 381M 2025-12
Coherus Biosciences USD 8.7M 853K 2025-12
Eli Lilly USD 15.92B 1.33B 2025-12
Fujifilm JPY 347.51B 14.74B 2025-12
Gilead Sciences USD 5.52B 791M 2026-03
Ironwood Pharmaceuticals USD 85.24M 44.1M 2025-06
Merck USD 10.85B 2.57B 2025-12
Myriad Genetics USD 146.8M 3M 2025-12
Pacira USD 126.64M 15.61M 2026-03
Perrigo USD 325.5M 36.7M 2026-03
Pfizer USD 11.04B 1.24B 2026-03
PTC Therapeutics USD 232.94M 84.56M 2026-03
Regeneron Pharmaceuticals USD 2.94B 363.7M 2026-03
Sarepta Therapeutics USD 621.34M 577.79M 2026-03
Teva Pharmaceutical Industries USD 2.11B 547M 2026-03
Vertex Pharmaceuticals USD 2.6B 121.7M 2026-03
Xencor USD 21M 22.61M 2025-09
Zoetis USD 1.62B 20M 2026-03